Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Body Mass index (BMI) of at least 30 kg/m² or BMI \>27 kg/m² with associated risk factors such as type 2 diabetes or dyslipidemia
You may not be if
Weight loss \> 5 kg within 3 months prior to screening Visit.
Presence of any clinically significant endocrine disease including the presence of type 1 diabetes
Presence of any severe medical or psychological condition that, in the opinion of the investigator, would compromise the patient's safe participation including uncontrolled serious psychiatric illness such a major depression within the last 2 years, and history of other severe psychiatric disorders
Previous participation in a clinical study with rimonabant
Administration of other investigational drugs, anti-obesity drugs or other drugs for weight reduction
Pregnancy and absence of effective contraceptive method for females of childbearing potential
Exenatide
Insulin therapy
Recent change or need for change in the oral antidiabetic treatment
Recent change or need for change in the lipid lowering treatment
Presence of severe renal or hepatic impairment
The above information is not intented to contain all considerations relevant to a patient's potential participation in a clinical trial.
